LIFr expression is a crucial condition for nevus/implanted melanoma transition; LIFr knockdown inhibits migration of melanoma cells in wound-healing tests; thus, LIFr could be a potential target for developing therapies in initial tumor interventions (Guo et al., 2015). Here, LIFR is linked to neoplasm.